Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Drik
865 Research Parkway, Suite 415
Oklahoma City, OK 73104
Phone: 405-202-0117
www.atdrik.com

Drik, is an affordable, personalized safety testing company. In addition to in silico approaches, we offer both in vivo (non-GLP and GLP with collaboration) and in vitro studies in slice cultures. Our aim is to provide a one-stop shop for services related to toxicology. In vivo studies include acute (maximum tolerated dose), sub-acute and sub-chronic toxicity studies in rat and dog by different routes of exposure. Toxicokinetic studies are offered by multiple routes of exposure including bio analysis of the compound in tissues of interest. Endpoints include body weight changes, food and water consumption, necropsy, clinical pathology, clinical chemistry and histopathology.

Key Contact
Name
Kumar Sripathirathan
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
08/12/13 $250,000 Series A i2E